Early detection of ovarian cancer: promise and reality.

Cancer treatment and research

Volumn 107, Issue , 2002, Pages 61-97

  Bast Jr , Robert C ^a   Urban, Nicole ^a   Shridhar, Viji ^a   Smith, David ^a   Zhang, Zhen ^a   Skates, Steven ^a   Lu, Karen ^a   Liu, Jinsong ^a   Fishman, David ^a   Mills, Gordon ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

ALGORITHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECHOGRAPHY; FEMALE; HUMAN; IMMUNOLOGY; MASS SCREENING; OVARY TUMOR; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THEORETICAL MODEL;

ALGORITHMS; CA-125 ANTIGEN; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MASS SCREENING; MODELS, THEORETICAL; OVARIAN NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036362116     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4757-3587-1_3     Document Type: Review

References (188)